Dr. Matis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
95 Chester Place
Southport, CT 06890Phone+1 203-521-2003
Education & Training
- University of ChicagoResidency, Internal Medicine, 1975 - 1977
- Perelman School of Medicine at the University of PennsylvaniaClass of 1975
Certifications & Licensure
- CT State Medical License 1993 - 2022
- MD State Medical License 1980 - 1993
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1991
Publications & Presentations
PubMed
- 104 citationsInducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway diseaseAmanda G. Tesciuba, Sumit K. Subudhi, Russell P. Rother, Susan J. Faas, Aric M. Frantz
Journal of Immunology. 2001-08-15 - 17 citationsEffective antigen-specific immunotherapy in the marmoset model of multiple sclerosis.Hugh I. McFarland, Adrian A. Lobito, Michele M. Johnson, Gregory R. Palardy, Christina S.K. Yee
Journal of Immunology. 2001-02-01 - 40 citationsPrimary Structure and Functional Characterization of a Soluble, Alternatively Spliced Form of B7-1Susan J. Faas, Michelle A. Giannoni, Angela P. Mickle, Cheri L. Kiesecker, Deborah J. Reed
Journal of Immunology. 2000-06-15
Press Mentions
- Pieris Pharmaceuticals and AstraZeneca Present Single- Ascending Dose Phase 1a Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at the American Thoracic Society (ATS) 2019 International ConferenceMay 22nd, 2019
- Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical DevelopmentOctober 12th, 2017
- Pieris Signs 1st Partnership for Anemia Drug PRS-080, Granting Exclusive Option in Japan to ASKA PharmaceuticalFebruary 27th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: